These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 33270095)

  • 1. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
    Cloutier MM; Dixon AE; Krishnan JA; Lemanske RF; Pace W; Schatz M
    JAMA; 2020 Dec; 324(22):2301-2317. PubMed ID: 33270095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
    Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
    Krings JG; Beasley R
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.
    Krings JG; Sekhar TC; Chen V; Blake KV; Sumino K; James AS; Clover AK; Lenze EJ; Brownson RC; Castro M
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2767-2777. PubMed ID: 37245736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
    Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
    Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
    Respirology; 2022 Jan; 27(1):14-35. PubMed ID: 34668278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting β
    Yorgancıoğlu A; Cruz AA; Garcia G; Lavoie KL; Roche N; Verma M; Majumdar A; Chatterjee S
    Respir Med; 2024 May; 226():107610. PubMed ID: 38561078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Aalbers R; Vogelmeier C; Kuna P
    Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Asthma Management Guidelines.
    Dubin S; Patak P; Jung D
    Mo Med; 2024; 121(5):364-367. PubMed ID: 39421468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries.
    Jayasooriya S; Stolbrink M; Khoo EM; Sunte IT; Awuru JI; Cohen M; Lam DC; Spanevello A; Visca D; Centis R; Migliori GB; Ayuk AC; Buendia JA; Awokola BI; Del-Rio-Navarro BE; Muteti-Fana S; Lao-Araya M; Chiarella P; Badellino H; Somwe SW; Anand MP; Garcí-Corzo JR; Bekele A; Soto-Martinez ME; Ngahane BHM; Florin M; Voyi K; Tabbah K; Bakki B; Alexander A; Garba BL; Salvador EM; Fischer GB; Falade AG; ŽivkoviĆ Z; Romero-Tapia SJ; Erhabor GE; Zar H; Gemicioglu B; Brandão HV; Kurhasani X; El-Sharif N; Singh V; Ranasinghe JC; Kudagammana ST; Masjedi MR; Velásquez JN; Jain A; Cherrez-Ojeda I; Valdeavellano LFM; Gómez RM; Mesonjesi E; Morfin-Maciel BM; Ndikum AE; Mukiibi GB; Reddy BK; Yusuf O; Taright-Mahi S; Mérida-Palacio JV; Kabra SK; Nkhama E; Filho NR; Zhjegi VB; Mortimer K; Rylance S; Masekela RR
    Int J Tuberc Lung Dis; 2023 Sep; 27(9):658-667. PubMed ID: 37608484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An innovative corticosteroid/long-acting β
    Usmani O; Roche N; Marshall J; Danagher H; Price D
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [No Abstract]   [Full Text] [Related]  

  • 19. Corticosteroid plus β
    Wang G; Zhang X; Zhang HP; Wang L; Kang Y; Barnes PJ; Wang G
    Respir Res; 2017 Dec; 18(1):203. PubMed ID: 29207999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
    Domingo C; Rello J; Sogo A
    Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.